To date, several groups have generated homologous models of endometriosis through the implantation of endometrial tissue fluorescently labeled by green fluorescent protein (GFP) or tissue from luciferase-expressing transgenic mice into recipient animals, enabling noninvasive monitoring of lesion signal. These models present an advantage over endpoint models, but some limitations persist; use of transgenic mice is laborious and expensive, and GFP presents poor tissue penetration due to the relatively short emission wavelength. For this reason, a homologous mouse model of endometriosis that allows in vivo monitoring of generated lesions over time and mimics human lesions in recipient mice would be most desirable. In this regard, using C57BL/6 and B6N-Tyr c-Brd /BrdCrCrl mice, we optimized a decidualization protocol to obtain large volumes of decidual endometrium and mimic human lesions. Subsequently, to obtain a more robust and reliable noninvasive monitoring of lesions, we used the fluorescent reporter mCherry, which presents deeper tissue penetration and higher photostability, showing that endometrial tissue was properly labeled with 1 × 10 8 PFU/mL mCherry adenoviral vectors. mCherry-labeled endometriotic tissue was implanted in recipient mice, generating lesions that displayed characteristics typical of human endometriotic lesions, such as epithelial cells forming glands, local inflammation, collagen deposits, and new vessel formation. In vivo monitoring demonstrated that subcutaneous implantation on ventral abdomen of recipient mice provided the most intense and reliable signal for noninvasive lesion monitoring over a period of at least 20 days. This homologous model improves upon previously reported models of endometriosis and provides opportunities to study mechanism underlying endometriotic lesion growth and progression. 
Summary Sentence Introduction
Endometriosis is a chronic disorder involving the implantation of functional endometrium outside the uterine cavity, leading to chronic pelvic pain and infertility [1] . Approximately 10%-15% of women of reproductive age develop endometriosis [2] , and it is present in up to 50% of infertile women [3] . Currently, there is not an effective pharmacological treatment for endometriosis that completely obliterates the lesions without causing side effects [4, 5] .
The quest for more efficient therapies requires the use of animal models in which human lesions can be appropriately mimicked, and the effects of compounds on lesion size, local inflammation, and new vessel formation (among others), as characteristics of human endometriosis, can be closely observed.
Primate models have been used to induce ectopic lesions histologically identical and at similar sites as human endometriosis [6] [7] [8] ; however, ethical considerations and the high cost of experiments using primates limit their use [9] . For this reason, endometriosis models in small animals, especially rodents, continue to be favored to allow studies in large numbers of animals [10, 11] . In contrast to humans, rodents do not shed their endometrial tissue and thereby do not develop endometriosis spontaneously. However, endometriosis can be induced in these animals by transplanting uterine tissue to ectopic sites. In this regard, heterologous models have been generated through the implantation of human endometrial fragments into immunodeficient animals. One of the drawbacks of these models is that they do not allow for an evaluation of the role of the immune system in establishing and maintaining endometriosis, making it difficult to interpret results [9] . To overcome this limitation, researchers have designed autologous and homologous animal models, in which complete uterus or only endometrium was implanted in the same animal or recipient animals [12] [13] [14] [15] [16] . However, lesions generated in these models do not reflect the physiological properties of human lesions since the tissue obtained from mice is not a properly "menstruating" endometrium. In this regard, Cheng et al. [17] developed a homologous mouse model of endometriosis, in which mouse decidual endometrium from donor mice was separated from the myometrium and used as a source of donor tissue to mimic the "menstruating" characteristics of human endometrium. Additionally, in contrast to conventional homologous models, this model did not require the exogenous administration of estradiol to allow for lesion survival and growth because the ovaries of recipient mice were intact and the endometriotic tissue was exposed to the normal, cyclical levels of reproductive hormones, allowing for infertility studies. However, the studies described above were endpoint animal models, in which it was not possible to study implantation dynamics or endometriotic lesion development over time, limiting the study of new drugs for endometriotic lesion therapy. In this regard, several groups have generated homologous models through the implantation of endometrial tissue fluorescently labeled by green fluorescent protein (GFP) or tissue from luciferase-expressing transgenic mice into recipient animals [18] [19] [20] , enabling noninvasive monitoring of the lesion signal. These models present an advantage over endpoint models, but some limitations persist; for example, the use of transgenic mice is laborious and expensive, and GFP presents poor tissue penetration due to the relatively short emission wavelength. For this reason, a homologous mouse model of endometriosis that allows in vivo monitoring of the generated lesions and mimics human lesions in recipient mice with intact ovaries would be most desirable. To that end, we developed a homologous mouse model of endometriosis that is more economical and accurate in which noninvasive monitoring of lesion size is possible over early time points in lesion development using mCherry adenoviral vector with 600 nm emission wavelength.
Material and methods

Animals and human endometrial tissue
Immature 8-week-old female C57BL/6 (wild-type) and B6N-Tyr c-Brd /BrdCrCrl (albino) mice from Charles River Laboratories (Barcelona, Spain) were used in this study. Animals were fed a standard chow diet ad libitum with a 12 h light and 12 h dark schedule. All surgical procedures were performed under general anesthesia with isoflurane (Abbott Laboratories, Queenborough, UK), and mice were observed until they were fully recovered. At the required endpoints, mice were killed by cervical dislocation. In vivo studies were conducted in accordance with the National Institutes of Health Guidelines (NIH; revised in 1985) for the care and use of laboratory animals. Protocols for animal handling were approved by the Institutional Animal Care Committee at the University of Valencia. Human endometriotic lesions (n = 3), used as control in immunohistochemical characterization of endometriotic lesions obtained in recipient mice, were collected from patients with endometriosis with approval by the institutional ethical committee (CEIC-IIslafe, Valencia, Spain); informed consent was obtained to collect the samples from patients included in the study.
Experimental design
A series of successive experiments were developed to generate the mouse model. The initial pilot experiments were designed to optimize the decidualization protocol to obtain decidual endometrium and to determine the efficiency of adenoviral vectors by fluorescently labeling the generated tissue. Subsequently, experiments were aimed at determining the implantation location and recipient mouse, which involved regular monitoring of lesion signal emission over time. In our final set of experiments, histological and immunohistochemical characterization of mouse endometriotic lesions in recipient mice was performed to determine whether the lesions appropriately mimic human endometriotic lesions.
Pilot experiments
Pilot experiment 1: optimization of uterus decidualization
To obtain large volumes of decidual endometrium and thus reduce the amount of donor tissue required for each recipient, donor mice were subjected to different decidualization protocols described in the literature [17, [21] [22] [23] , with some modifications. Briefly, female C57BL/6 donor mice (N = 20) were ovariectomized and hormonally stimulated with daily injections of estradiol and/or progesterone at different doses (see Tables 1-3) . Decidualization was induced 4-6 h after hormonal administration on day (D) 8 by the injection of 20 μL of warm peanut oil (Sigma-Aldrich, St. Louis, MO, USA) inside the uterine horn or by unilateral scratching on the antimesometrial lumen with a 27-G needle inside each horn.
Sixty hours after injection, mice were killed and the uterus was recovered, macroscopically observed, and photographed. A caliper was used to measure the height and width of each uterine horn, and the volume (V) was determined by the formula V = height r 2 π, expressed as mm 3 ; the sum of both uterine horn volumes determined the total uterus size. Decidual endometrium was collected from donor mice by gently squeezing each uterine horn with the back of a pair of curved forceps such that the endometrial tissue was expelled into a small volume of culture medium to be washed as previously described [17] . Decidual endometrium was maintained in DMEM/F-12 medium with 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA, USA), 1 μg/mL fungizone antimycotic (Life Technologies, Carlsbad), and 1% penicillin/streptomycin (Sigma-Aldrich) until fluorescent labeling was performed.
Pilot experiment 2: determination of fluorescent labeling efficiency Tissue infection. Due to the complex and slow proliferation nature of endometrium and the importance of maintaining the threedimensional structure of endometriotic lesions in recipient mice, we chose adenoviruses, which can transduce with high efficiency numerous tissues, including nondividing cells [24] , as vectors for introducing mCherry cDNA into whole endometrial fragments. Furthermore, a preliminary study performed by our group showed that mCherry lentiviral particles were not able to label endometrial tissue with high efficiency (data not shown); thus, we concluded that lentiviruses are not suitable for infecting endometrial explants and, in consequence, adenoviruses were a better option.
Decidual endometrium obtained from donor mice was cut into approximately 3-5 mm 3 pieces, distributed into 96-well plates (three fragments per well), and incubated overnight at 37
• C with 5% CO2
in DMEM/F-12 and 10% FBS without antibiotics and with 0 and 1 × 10 8 plaque-forming units (PFU)/mL of mCherry adenoviral particles (Vector Biolabs, Malvern, PA, USA). The concentration of mCherry adenovirus was chosen based on preliminary studies (data not shown). A small part of the decidual endometrium was cultured without mCherry adenoviral vectors to obtain a negative control. After 18 h of incubation with adenoviral particles, supernatant was removed and endometrial tissue washed twice with phosphatebuffered solution (PBS) (Gibco) to be implanted in recipient mice.
Determination of infection efficiency. mCherry-labeled and unlabeled tissues were fixed in 4% neutral buffered formalin overnight at 4
• C before being embedded in paraffin wax and cut into 5-μm sections. After antigen retrieval with citrate buffer, sections were blocked with 2% goat normal serum and 5% BSA for 1 h at room temperature and incubated with primary goat anti-mCherry antibody (Biorbyt, Cambridge, UK) overnight at 4 • C. Samples were then incubated with an anti-goat biotinylated secondary antibody (1:500; Vector Laboratories, Burlingame, CA) for 30 min at room temperature before the addition of fluorescent dye conjugate of streptavidin AlexaFluor594 at 1:1500 (Molecular Probes; Life Technologies) and counterstaining with DAPI (Life Technologies) (Supplementary Table S1 ). Fluorescent signals were captured with the Leica DMI 3000B fluorescence microscope (Leica Microsystems Inc, Buffalo Grove, IL, USA). Four fluorescent images were quantified by Image ProPlus 6.0 Software (Media Cybernetics, Silver Spring, MD, USA) to determine the infection efficiency using protocols previously employed by our group [25] . Results were expressed as mCherry-stained area/total area × 100.
Animal model Experiment 1: effect of implant localization on in vivo monitoring of endometriotic lesions
To evaluate how the localization of the implants affected fluorescent signal over time, labeled endometrial fragments were randomly divided into three groups and implanted into immunocompetent recipient mice (N = 3 per group) with intact ovaries in different locations, generating one lesion per animal: (a) (Back) in a subcutaneous pocket in the back with 15% matrigel (Cultek, Madrid, Spain) as a substrate to maintain the tissue consistency; (b) (Abdomen) in a subcutaneous pocket on the ventral abdomen with 15% matrigel, or (c) intraperitoneally on the left side of the mouse (IP), using n-butylester cyanoacrylate adhesive (Vetbond; 3M Animal Care, MN, USA) to adhere the tissue in the peritoneum, such as our intraperitoneal endometriotic lesions in previous studies were generated [26] and unlabeled fragments were implanted on the right side of the same mouse, as a control (IP-CT). Unlabeled endometrial fragments divided into two groups and implanted into recipient mice (n = 3 per group) in (a) (CT-Back) subcutaneous pocket in the back and (b) (CT-Abdomen) subcutaneous pocket on the ventral abdomen with 15% matrigel.
Noninvasive fluorescent monitoring
For noninvasive imaging of mCherry-expressing endometrial tissue, mice were anesthetized with isoflurane, the area around the transplantation site was shaved, and the mice were placed on a black platform. Mice were observed in vivo every 4 days for 20 days after receiving the tissue implant using a Carestream in vivo FX-PRO (Bruker, Madrid, Spain). mCherry expression was observed using an excitation wavelength of 550 nm for 40 s and an emission wavelength of 600 nm, and the fluorescent images were acquired by a digital camera (Olympus, Tokyo, Japan). To assess lesion size in each mouse, a quantitative analysis from these fluorescent images was performed using Image J software (NIH, Bethesda, MD CrCrl an albino strain (Albino). To do this, labeled endometrial fragments from black and albino donor mice were implanted into their respective recipient mice strain (N = 3 per group) in a subcutaneous pocket on the ventral abdomen with 15% matrigel, generating one lesion per animal. Unlabeled endometrial fragments from albino donor mice were implanted into the albino recipient mice (N = 3) as a negative control. Noninvasive monitoring of mCherry-expressing endometrial tissue was performed every 4 days, as described above.
Characterization of induced endometriotic lesions
To determine whether the endometriotic lesions implanted in recipient mice demonstrate human endometriotic lesion characteristics, mice were killed 20 days after endometrial tissue implantation. The peritoneal cavity was accessed, and the visceral organs were found to be healthy and normal in all of the mice. Lesions were observed macroscopically, then recovered and fixed in 4% neutral formalin and embedded in paraffin for histological and immunohistochemical characterization. Human endometriotic lesions were used as control in immunohistochemical characterization of endometriotic lesions obtained in recipient mice.
Immunohistochemical profiling of lesions
Endometriotic lesions fixed in 4% neutral-buffered formalin overnight at 4
• C were embedded in paraffin wax and cut into 5-μm sections. After antigen retrieval with citrate buffer, sections were incubated with a PBS blocking solution containing 2% normal serum (Thermo Scientific, Walldorf, Germany) matching the secondary antibody plus 5% BSA (Roche, Basel, Switzerland). Primary antibodies were incubated as described in Supplementary Table S1 . Negative controls were left in the blocking solution without primary antibody. Sections were then incubated with the appropriate secondary biotinylated antibody for each primary antibody for 30 min at room temperature followed by treatment with the ABC kit (Vector Laboratories). The color modification reaction was performed with DAB (Vector Laboratories), and signals were visualized with a Leica DMI 3000B microscope.
Masson trichrome stain
Paraffin-embedded lesions were cut into 5-μm section and deparaffinized, and Masson trichrome stain was used to define collagen deposition, according to the manufacturer's instructions (SigmaAldrich). Collagen deposits were stained blue while muscle fibers and fibrin were stained red/pink.
Immunofluorescent characterization of lesions
Immunofluorescence of alpha-smooth muscle actin (α-SMA) was performed in combination with fluorescein-labeled Griffonia simplicifolia isolectin B4 (IB4) for mouse lesions or goat anti-human CD31 antibody for human lesions, a marker of endothelial cells, to detect the presence of mature and immature vessels. To do this, sections were incubated with primary antibodies described in supplementary Table 1 . Human tissue sections were incubated with goat biotinylated secondary antibody and AlexaFluor 488. Images were obtained with a Leica DMI 3000B (Leica Microsystems Inc.) fluorescence microscope.
Statistical analyses
Statistical analysis was performed using SPSS 15.0 (Inc., Chicago, IL, USA) and data were expressed as mean ± standard deviation (SD). ANOVA was used to compare the uterus size from different decidualization protocols. The nonparametric Kruskal-Wallis test followed by the Mann-Whitney U test was used to compare differences in lesion signals obtained during in vivo monitoring. Differences were considered to be statistically significant when * P < 0.05 and * * P < 0.01.
Results
Pilot experiment 1: optimization of uterus decidualization protocol
Initially, we induced decidual endometrium in black mice using the hormonal protocol described by Cheng et al. [17] (Table 1) . Uteri presented a whitish color, indicating poor vascularization, and a size and thickness lower than observed in other studies; the average uterus size was 19.4 mm 3 ± 3.65 [ Figure 1A (a.a) and B]. These findings suggest that the decidualization protocol described by Cheng et al. (Table 1 ) could be modified to obtain a large amount of decidual endometrium.
To improve uterus decidualization and obtain higher volumes of donor tissue, black mice were subjected to the decidualization protocols described in the literature [21] [22] [23] (Tables 2 and 3) . Compared with uteri obtained in the decidualization protocol described by Cheng et al. (Table 1) , we obtained more vascularized, larger, and thicker uteri. These improvements were even more evident when decidualization was induced by the injection of peanut oil into the uterine lumen and progesterone was administrated on D9-D10 until death (total volume: 73.6 mm 3 ± 3.57) [ Figure 1A (a.b) and B].
Uteri subjected to scratching were smaller (16.8 mm 3 ± 4.56; 17.7 mm 3 ± 3.45) than uteri injected with peanut oil (73.6 mm 3 ± 3.57; 37.5 mm 3 ± 2.34), regardless of prolonged progesterone administration [ Figure 1A (a.b-a.e) and B].
Pilot experiment 2: determination of fluorescent labeling efficiency
After incubation overnight of endometrial tissue fragments from donor mice with mCherry adenoviral vectors, we corroborated that these endometrial fragments were properly transfected, monitoring the fluorescence presence by fluorescence microscope. We observed mCherry signal in the endometrial tissue incubated with 1 × 10 8 PFU/mL, while no signal was observed in control tissue incubated without mCherry adenoviral vectors (Figure 2A) . A labeling efficiency of 23.04% was observed when tissue was labeled using 1 × 10 8 PFU/mL of mCherry adenoviral vectors, while 0% fluorescence was observed in control tissue ( Figure 2B ).
Experiment 1: establishment and in vivo monitoring of endometriotic lesions
mCherry-labeled endometrial tissue was implanted in different locations in C57BL/6 (black) recipient mice and monitored in vivo to determine the location in which endometriotic lesions provide the most intense and reliable signal. We were unable to monitor the subcutaneous lesions generated in the back of recipient animals, because endometriotic lesions were not present in the location where endometriotic tissues were implanted initially. However, these lesions were visible macroscopically in other locations, when animals were euthanized 20 days after tissue implantation ( Figure 3C ); implantation of endometrial tissue in the back therefore makes lesion monitoring difficult. When lesions were established subcutaneously on the ventral abdomen, fluorescent signals could be monitored ( Figure 3A and B), and they decreased over time (708.78 mm 2 of these black mice, which impeded its visualization, but on D12 this signal increased again compared with D8 (466.07 mm 2 AU ± 80.65),
following the disappearance of the stain ( Figure 3A and B). We investigated the possible causes of this stain and realized that it was due to changes in skin pigmentation of black mice that masked the lesion signal ( Figure 3A , Supplementary Figure S1 ), with the greatest skin pigmentation observed on D8. Intraperitoneal lesions were monitored via a weak signal (Figure 3A and B) compared with subcutaneous lesions on the ventral abdomen (570.41 mm 2 AU ± 55.80 vs 708.78 mm 2 AU ± 62.25 in D4) throughout the 20 days. As such, we determined that in vivo monitoring of these lesions is most easily performed using subcutaneous lesions on the ventral abdomen. We observed endometriotic lesions macroscopically when recipient mice were killed 20 days after the implantation ( Figure 3C ). In addition, mCherry expression was detected in these lesions by immunohistochemistry, indicating that lesions were generated by the endometrial tissue from donor mice transfected with mCherry adenoviral vector ( Figure 3D ).
Experiment 2: in vivo monitoring of lesions in C57BL/6 and B6N-Tyrc-Brd /BrdCrCrl mice
To avoid skin pigmentation changes characteristic of C57BL/6 (black) mice, we used an albino strain of C57BL/6 (B6N-Tyrc-Brd/ BrdCrCrl) (hereafter designated albino), which has a mutation in the tyrosinase gene. When homozygous for this mutation, the coat color of the mice is albino instead of black. We generated subcutaneous endometriotic lesions on the ventral abdomen, the location that provided the most intense and reliable signal, in albino and black mice and observed that lesions generated in albino mice could be more specifically monitored in vivo compared with lesions generated in black mice, in which skin pigmentation masked the mCherry signal ( Figure 4A) .
On the first day of in vivo monitoring (D4), albino mice exhibited an intense signal (1701 mm 2 Figure 4A and B), coinciding with reduced skin pigmentation, as we observed in experiment 1.
It is important to mention that in the first days after implant surgery, control mice exhibit an unspecific signal due to the incision scar ( Figure 4A ). This scar generates an initial fluorescence emitted at a similar wavelength to mCherry, but the signal expires when the scar disappears.
Characterization of induced endometriotic lesions
Recipient animals from experiment 2 were killed 20 days after tissue implantation, and lesions were visible macroscopically ( Figure 4C ), showing that we were able to generate endometriotic lesions in recipient mice. mCherry immunohistochemistry of the lesions obtained from recipient mice revealed that these lesions were generated by the endometrial tissue from donor mice transfected with mCherry adenoviral vector ( Figure 4D ).
We observed epithelial cells forming glands characteristic of human endometriotic lesions ( Figure 5A ). Since endometriosis is associated with local inflammation [4] , which causes an increase in activated macrophages and leukocytes, we investigated the presence of these immune cells in our model of endometriotic lesions. We observed macrophages and leukocytes in the mouse lesions, supporting local inflammation characteristics typical of human endometriosis ( Figure 5B and C) . Negative controls in supplementary Figure S2 . In addition, collagen deposits surrounded the glands and the periphery of the lesions ( Figure 5D ), which is also a characteristic of human endometriotic lesions.
Vascularization of endometriotic implants is one of the most important factors in the invasion of other tissues by endometrial cells. Therefore, new vessel formation is present in human endometriotic lesions ( Figure 5F ). In this regard, we observed angiogenic blood vessels via I-B4 immunofluorescence, indicating new vessel formation. This, along with the cellular proliferation observed by Ki67 immunohistochemistry ( Figure 5E and F) , is suggestive of lesion development. Controls in Supplementary Figure S2 .
Discussion
In this study, we present a homologous mouse model of endometriosis that uses endometrial tissue from donor mice labeled by mCherry , and intraperitoneally (IP and IP-CT) 20 days after the endometrium was implanted. Square marks signal due to the scar produced in implant surgery. Note that while subcutaneous lesions in the back (Back and CT-Back) could not be monitored in vivo, subcutaneous lesions on the ventral abdomen could be monitored over time, but not properly due to the skin pigmentation changes that masked the lesion signal. The intraperitoneal signal was weaker than the subcutaneous signal. White ruler in macroscopic images = 1 mm, * P < 0.05, * * P < 0.01 compared with the first day of monitoring (D4). adenoviral vector to noninvasively monitor lesion growth over early time points in lesion development. Noninvasive monitoring of a fluorescent signal enables the study of implantation dynamics and development of endometriotic lesions over time. Furthermore, this approach reduces the number of animals needed for study because the same animals can be evaluated for lesion measurements at different time points. Together, these features provide a more rapid mode of evaluating new drugs for endometriotic lesion therapy. For this reason, several noninvasive monitoring homologous models of endometriosis have been established to date [18] [19] [20] . However, these models did not generate decidual endometrium to be inoculated in ectopic sites and generate endometriotic lesions. Cheng et al. [17] developed an animal model in which decidualized endometrium was implanted in recipient mice to generate lesions, which are exposed to cyclical hormone levels since the ovaries of recipient mice remain intact. Although this model is more physiological than others, it is an endpoint animal model and presents a poor uterus decidualization. To avoid these limitations and improve the model, we evaluated several uterus decidualization protocols described in the literature [21] [22] [23] and demonstrated that the uterus could be properly decidualized using 1 mg/day of progesterone on D6-D10 until euthanization, and peanut oil injection at D8. The advantage of our model is that it necessitates the use of only two donor mice per recipient animal, providing cost, time, and energy savings, and it provides the opportunity to study lesion development over time.
To obtain a more robust and reliable noninvasive monitoring of the signal than GFP labeling, and to acquire a homologous mouse model that is more economical than transgenic mice, we used a red fluorescent reporter with far-red emission spectra, mCherry [27, 28] , for in vivo labeling of endometrial tissue, which presents deeper tissue penetration and higher photostability. We showed that 1 × 10 8 PFU/mL of mCherry adenoviral vectors were able to label the decidual endometrium with a labeling efficiency of 23.04%. This percentage is considered a high labeling efficiency using adenoviral particles; indeed, other studies have described that 15%-40% of cells expressing the foreign gene is considered a relatively high infection rate because adenoviruses are expected to penetrate only the outer layers of the endometrial fragments [24] , meaning that with 1 × 10 8 PFU/mL of mCherry adenoviral vectors the vast majority of these outer layer cells have been infected. These results are consistent with the mCherry adenoviral concentration used to label human endometrium in our recently published noninvasive monitoring heterologous model of endometriosis [26] . Based on these findings and considering that in vivo monitoring in this model and transgenic mice model require imaging equipment, we conclude that, if the research group has access to imaging equipment, this model is advantageous over the use of transgenic animals because generation and maintenance of transgenic models costs more than the use of wild-type mice and adenovirus. Although an intraperitoneal implant can represent the development and growth of human endometriosis, intraperitoneal implantation in recipient mice resulted in random implantation sites and sometimes in loss of endometriotic tissue into the peritoneal cavity, which decreased the signal and increased variability of in vivo monitoring, thereby affecting comparisons between groups. For this reason, we demonstrated that subcutaneous implantation on the ventral abdomen of mCherry endometrial tissue in wild-type albino recipient mice (B6N-Tyrc-Brd /BrdCrCrl), which lack skin pigmentation that can alter signal monitoring, provided the most robust and reliable signal for noninvasive lesion monitoring over a period of at least 20 days; these findings support a study in which the authors concluded that subcutaneous transplantation is preferable [20] . The reason for our limited observation time is that adenoviruses express exogenous genes transiently, preventing noninvasive monitoring over longer periods of time. We are aware that 20 days of noninvasive observation is a limitation if the objective is to study the development of endometriotic lesions over time [24] . However, our approach is a strength when this model is compared with endometriosis models in which lesions are observed at the end of the treatment. For this reason, we must specify that this model does not allow noninvasive monitoring over long periods of time, but it allows noninvasive monitoring over early time points in lesion development. Therefore, this model might be interesting to study the mechanisms that are implicated in the establishment and early development of the endometriotic lesions. Nevertheless, we will continue to develop adenoviral and lentiviral expression systems that allow longer in vivo monitoring.
Importantly, the presence of lesions visible macroscopically after death, in which mCherry-expressing cells were detected, indicated the ability of donor endometrial tissue to generate endometriotic lesions without the use of K-Ras transgenic donor mice, as described Cheng et al. [17] . Furthermore, lesions generated in this study portrayed characteristics typical of human endometriosis as well as angiogenesis and proliferation, as described previously in other studies [4, 17, 30] , which indicated the establishment and development of lesions very similar to those in humans [29, 31] .
Our model unifies the advantages described in other animal models of endometriosis. We describe the use of immunocompetent recipient mice with intact ovaries carrying endometrial tissue labeled with fluorescent reporters with high tissue penetration for ongoing in vivo monitoring, allowing for the possibility of measuring lesion growth without the need to cull mice at different time points. This approach is more economical, accurate, and predictive than existing models and provides an opportunity to research the mechanism underlying endometriotic lesion growth and progression, endometriotic drug action, and the role of the immune system in endometriosis. Therefore, this homologous model could be a promising preclinical tool for the assessment of new drug efficacy to treat endometriosis.
Supplementary data
Supplementary data are available at BIOLRE online. Table S1 . Antibodies used in immunohistochemistry and immunofluorescence.
Supplementary
Supplementary Figure S1 . C57BL/6 mice presented changes in skin pigmentation. Images show changes in skin pigmentation throughout the 20 days of monitoring in C57BL/6 mice. Note that these changes in skin pigmentation masked the fluorescence signal, altering the monitoring of the signal.
Supplementary Figure S2 . Immunohistochemical positive and negative controls of (A) epithelial cells (using anti-cytokeratin antibody) in skin. 
